Drug Profile
Research programme: small molecule therapeutics - Pfizer/X-Chem
Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Pfizer; X-Chem
- Class Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Inflammation in USA
- 11 Jun 2014 Early research in Inflammation in USA (unspecified route)